TY - JOUR
T1 - Influence of Process Parameters on the Heterogeneous Nucleation of Active Pharmaceutical Ingredients onto Excipients
AU - Arribas Bueno, Raquel
AU - Crowley, Clare M.
AU - Hodnett, Benjamin K.
AU - Hudson, Sarah
AU - Davern, Peter
N1 - Publisher Copyright:
© 2017 American Chemical Society.
PY - 2017/4/21
Y1 - 2017/4/21
N2 - It is known that chemical and physical compatibility between a heterosurface and the crystallizing molecule promotes heterogeneous nucleation. In this work, acetaminophen (AAP), α/β-lactose (α/β-Lac), and methanol (MeOH) were selected as the model active pharmaceutical ingredient, excipient, and solvent, respectively. The excipient - suspended in a supersaturated solution of AAP in MeOH - was used as a heterogeneous surface ("seed"), and parameters influencing the heterogeneous nucleation of the AAP, such as (a) AAP solution/excipient contact time, (b) AAP supersaturation, and (c) AAP to excipient loading, were varied to demonstrate how the nucleation rate and the degree of crystallization can be manipulated to control the particle size and the balance between nucleation and growth. In this regard, the crystallizations were performed at a supersaturation which was shown not to promote nucleation of AAP up to 2 h in the absence of α/β-Lac. Thereafter, during the heterogeneous crystallizations of AAP in the presence of α/β-Lac, AAP particles nucleated on the α/β-Lac surface and then grew uniformly, producing small AAP particles (<15 μm) in a robust manner such that the particle size distribution was maintained constant over a range of contact times, supersaturations, and AAP loadings (%).
AB - It is known that chemical and physical compatibility between a heterosurface and the crystallizing molecule promotes heterogeneous nucleation. In this work, acetaminophen (AAP), α/β-lactose (α/β-Lac), and methanol (MeOH) were selected as the model active pharmaceutical ingredient, excipient, and solvent, respectively. The excipient - suspended in a supersaturated solution of AAP in MeOH - was used as a heterogeneous surface ("seed"), and parameters influencing the heterogeneous nucleation of the AAP, such as (a) AAP solution/excipient contact time, (b) AAP supersaturation, and (c) AAP to excipient loading, were varied to demonstrate how the nucleation rate and the degree of crystallization can be manipulated to control the particle size and the balance between nucleation and growth. In this regard, the crystallizations were performed at a supersaturation which was shown not to promote nucleation of AAP up to 2 h in the absence of α/β-Lac. Thereafter, during the heterogeneous crystallizations of AAP in the presence of α/β-Lac, AAP particles nucleated on the α/β-Lac surface and then grew uniformly, producing small AAP particles (<15 μm) in a robust manner such that the particle size distribution was maintained constant over a range of contact times, supersaturations, and AAP loadings (%).
UR - http://www.scopus.com/inward/record.url?scp=85018497166&partnerID=8YFLogxK
U2 - 10.1021/acs.oprd.6b00425
DO - 10.1021/acs.oprd.6b00425
M3 - Article
AN - SCOPUS:85018497166
SN - 1083-6160
VL - 21
SP - 559
EP - 570
JO - Organic Process Research and Development
JF - Organic Process Research and Development
IS - 4
ER -